Business

MedX Health Reports 2012 and First Quarter 2013 Financial Results

MISSISSAUGA, ON, June 7, 2013 /CNW/ - MedX Health Corp., (TSXV.MDX) a global leader in ...

articleMedx Health Corp.June 7, 20134/company/medx-health-corp/news/medx-health-reports-2012-and-first-quarter-2013-financial-results
MedX Health Reports 2012 and First Quarter 2013 Financial Results

About this update from Medx Health Corp.

[{"type":"text","content":"\n\n\nMISSISSAUGA, ON, June 7, 2013 /CNW/ - MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser light therapy\n for tissue repair and pain relief have reported their revenues for 2012\n and the first quarter of 2013.  Please see www.SEDAR.com for the actual filings.\n\n\nAbout MedX Health Corp.\n\n\nMedX is a twelve (12) year old Canadian company, headquartered in\n Mississauga, Ontario (Toronto), and is a global leader in the design,\n manufacturing and distribution of quality low level laser and light\n therapy technologies for use in numerous medical settings, including\n rehab/chiropractic, dental, wound care, and veterinary medicine,\n providing patients with drug free and non-invasive treatment of tissue\n damage and pain. MedX laser and light products are FDA approved, Health\n Canada cleared, and CE Mark approved for use in North America as well\n as the European Union. MedX Health acquired the worldwide assets of\n MoleMate in June, 2011. For a complete profile of MedX Health Corp. and\n its products visit www.medxhealth.com.\n\n\nAbout MoleMate Imaging and Skin Cancer\n\n\nMoleMate recently received approval from Health Canada, and is\n immediately available and in stock for all Canadian physicians, joining\n their colleagues in Europe, the UK, Australia, and the US, who have\n been utilizing this new pain-free, non-invasive imaging system to 'See\n More', approximately 2mm below the surface of suspicious moles, and\n provide additional information and images related to every mole and all\n types of melanomas and non-melanomas.\n\n\nMoleMate uses a patented device and technology that features a hand-held\n scanner designed for office use that utilizes light to view beneath\n suspicious moles or lesions in a pain free, non-invasive manner,\n creating images for physicians to evaluate all types of moles and\n lesions within seconds, providing images that can reveal if a mole is\n benign, or something more serious, often eliminating the need for skin\n biopsies, resulting in less pain, scarring, and expense. Physicians\n interested in learning more should contact MedX Health Corp. at www.simsys-molemate.com.\n\n\nThis press release does not constitute an offer of any securities for\n sale. This press release contains certain forward-looking statements\n within the meaning of appli...

More updates from Medx Health Corp.